Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06002191 · ClinicalTrials.gov registry record · NA

Development and Testing of imHere4U: A Digital Suicide Prevention Intervention for Cyberbullied Adolescents

A NA study of Suicidal Ideation and Psychological Distress, sponsored by University of Pittsburgh.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT06002191: Recruiting NA study of Suicidal Ideation and Psychological Distress, sponsored by University of Pittsburgh.

NCT06002191 is a NA study of Suicidal Ideation and Psychological Distress that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 80 participants, below the 267-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06002191, a NA study of Suicidal Ideation and Psychological Distress, is actively recruiting participants, sponsored by University of Pittsburgh.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to test the feasibility and preliminary efficacy of Flourish (formerly referred to as imHere4U), a digital suicide prevention intervention for cyberbullied adolescents. The specific aims are to: Aim #1: Conduct a randomized controlled trial (RCT) comparing Flourish+Questionnaires vs. Questionnaires Alone among cyberbullied youth at-risk for suicide ages 12-17 (N=80, \>35% underserved youth). H2a. Primary outcome: Feasibility will be evidenced by recruitment/retention rates \> 80% and imHere4U engagement \> 70%. H2b. Secondary outcomes: Youth assigned to Flourish+Questionnaires will report improved problem-solving capacity, distress tolerance, and motivation and reduced distress and suicidal ideation than youth assigned to Questionnaires Alone over the 6-month follow-up period. Exploratory Aim: Examine the feasibility of delivering feedback on online interactions from machine learning algorithms. All youth assigned to Flourish may optionally provide their social media data to receive feedback from machine learning algorithms. H3a. Feedback from algorithms will have high acceptability (identified via qualitative themes and \>70% acceptance rates) and usability, defined by mean scores on Post-Study System and Usability Questionnaire (PSSUQ) \> 6.

Primary Outcome

Feasibility will be measured through recruitment rates of eligible participants, using a cut-off score of 80% for desirable recruitment rates.

Interventions

  • BEHAVIORAL Flourish
  • BEHAVIORAL Questionnaires of Online Experiences

Study Locations (1)

Pennsylvania

  • University of Pittsburgh Medical Center - Pittsburgh

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2023-11-21
Est. Completion 2026-08
Phase NA
University of Pittsburgh

1,238 total trials

What NCT06002191 shows while recruiting

NCT06002191 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 267-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (70% lower).

The record links to 2 conditions, with Suicidal Ideation appearing as the primary indexed condition, and to 2 interventions - of which Flourish is the first listed.

NCT06002191 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06002191 about?

NCT06002191 is a clinical study titled "Development and Testing of imHere4U: A Digital Suicide Prevention Intervention for Cyberbullied Adolescents". The objective of this study is to test the feasibility and preliminary efficacy of Flourish (formerly referred to as imHere4U), a digital suicide prevention intervention for cyberbullied adolescents. The specific aims are to: Aim #1: Conduct a randomized controlled trial (RCT) comparing Flourish+Q...

What is the current status of trial NCT06002191?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2023-11-21. Estimated completion is 2026-08.

What conditions does trial NCT06002191 study?

This clinical trial studies the following conditions: Suicidal Ideation, Psychological Distress.

What interventions are being tested in trial NCT06002191?

The interventions under investigation include: Flourish (BEHAVIORAL), Questionnaires of Online Experiences (BEHAVIORAL).

Who is sponsoring clinical trial NCT06002191?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06002191 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Suicidal Ideation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06002191's enrollment target sits among peer trials

80 47th of 84 higher than 34 of 84 other Suicidal Ideation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Suicidal Ideation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06002191, the US trial registry maintained by the National Library of Medicine. NCT06002191 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.